The human papillomavirus type 16 E5-protein modulates ligand-dependent activation of the EGF receptor family in the human epithelial cell line HaCaT

Experimental Cell Research

Volumn 241, Issue 1, 1998, Pages 76-83

  Crusius, Kerstin ^a   Auvinen, Eeva ^a,b   Steuer, Barbara ^a   Gaissert, Heike ^a   Alonso, Angel ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOPHOSPHORYLATION; CELL PROLIFERATION; DIMERIZATION; DRUG RECEPTOR BINDING; EPITHELIUM CELL; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INTERNALIZATION; LIGAND BINDING; MULTIGENE FAMILY; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN MODIFICATION; RECEPTOR UPREGULATION; WART VIRUS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES;

EID: 0031818511     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1998.4024     Document Type: Article

References (30)

1. van der Geer, P., Hunter, T., and Lindberg, R. A. (1994). Receptor protein-tyrosine kinases and their signal transduction pathways. Annu. Rev. Cell Biol. 10, 251-337.
2. Ullrich, A., and Schlessinger, J. (1990). Signal transduction by receptors with tyrosine kinase activity. Cell 61, 203-212.
3. Carpenter, G., and Cohen, S. (1990). Epidermal growth factor. J. Biol. Chem. 265, 7709-7712.
4. Cano, E., and Mahadevan, L. C. (1995). Parallel signal processing among mammalian MAPKs. Trends Biochem. Sci. 20, 117-121.
5. Feng, G. S., and Pawson, T. (1994). Phosphotyrosine phosphatses with SH2 domains: Regulators of signal transduction. Trends Gen. 10, 54-58.
6. Wiley, H. S., Herbst, J. J., Walsh, B. J., Lauffenburger, D. A., Rosenfeld, M. G., and Gill, G. N. (1991). The role of tyrosine kinase activity in endocytosis, compartmentation, and down-regulation of the epidermal growth factor receptor. J. Biol. Chem. 266, 11083-11094.
7. Baulida, J., Krauss, M. H., Alimandi, Di Fiore P. P., and Carpenter, G. (1996). All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired. J. Biol. Chem. 271, 5251-5257.
8. Beerli, R. R., and Hynes, N. E. (1996). Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities. J. Biol. Chem. 271, 6071-6076.
9. zur Hausen, H. (1991). Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 184, 9-13.
10. Leechanachai, P., Banks, L., Moreau, F., and Matlashewski, G. (1992). The E5 gene from the human papillomavirus type 16 is an oncogene which enhances growth factor-mediated signal transduction to the nucleus. Oncogene 7, 19-25.
11. Leptak, C., Ramón y Cajal, S., Kulke, R., Horwitz, B. H., Riese, D. J., II, Dotto, G. P., and DiMaio, D. (1991). Tumorigenic transformation of murine keratinocytes by the E5 genes of bovine papillomavirus type 1 and human papillomavirus type 16. J. Virol. 65, 7078-7083.
12. Bouvard, V., Matlashewski, G., Gu, Z. M., Storey, A., and Banks, L. (1994). The human papillomavirus type 16 E5 gene cooperates with the E7 gene to stimulate proliferation of primary cells and increase viral gene expression. Virology 203, 73-80.
13. Conrad, M., Bubb, V. J., and Schlegel, R. (1993). The human papillomavirus type 6 and 16 E5 proteins are membrane-associated proteins which associate with the 16-kilodalton pore-forming protein. J. Virol. 67, 6170-6178.
14. Oelze, I., Kartenbeck, J., Crusius, K., and Alonso, A. (1995). Human papillomavirus type 16 E5 protein affects cell-cell communication in an epithelial cell line. J. Virol. 69, 4489-4494.
15. Pim, D., Collins, M., and Banks, L. (1992). Human papillomavirus type 16 E5 gene stimulates the transforming activity of the epidermal growth factor receptor. Oncogene 7, 27-32.
16. Conrad, M., Goldstein, D., Andresson, T., and Schlegel, R. (1994). The E5 protein of HPV-6, but not HPV-16, associates efficiently with cellular growth factor receptors. Virology 200, 796-800.
17. Hwang, E. S., Nottoli, T., and DiMaio, D. (1995). The HPV16 E5 protein: Expression, detection, and stable complex formation with transmembrane proteins in COS cells. Virology 211, 227-233.
18. Straight, S. W., Herman, B., and McCance, D. J. (1995). The E5 oncoprotein of human papillomavirus type 16 inhibits the acidification of endosomes in human keratinocytes. J. Virol. 69, 3185-3192.
19. Straight, S. W., Hinkle, P. M., Jewers, R. J., and McCance, D. J. (1993). The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes. J. Virol. 67, 4521-4532.
20. Böhmer, F. D., Böhmer, A., Obermeier, A., and Ullrich, A. (1995). Use of selective tyrosine kinase blockers to monitor growth factor receptor dephosphorylation in intact cells. Anal. Biochem. 228, 267-273.
21. Stoler, M. H., Rhodes, C. R., Whitbeck, A., Wolinske, S. M., Chow, L. T., and Broker, T. R. (1992). Human papillomavirus type 16 and 18 gene expression in cervical neoplasias. Hum. Pathol. 23, 117-128.
22. Bauer-Hofmann, R., Borghouts, C., Auvinen, E., Bourda, E., Rösl, F., and Alonso, A. (1996). Genomic cloning and characterization of the non-occupied allele corresponding to the integration site of human papillomavirus type 16 DNA in the cervical cancer cell line SiHa. Virology 217, 33-41.
23. Kell, B., Jewers, R. J., Cason, J., Pakarian, F., Kaye, J. N., and Best, J. M. (1994). Detection of E5 oncoprotein in human papillomavirus type 16-positive cervical scrapes using antibodies raised to synthetic peptides. J. Gen. Virol. 75, 2451-2456.
24. Drummond-Barbosa, D. A., Vaillancourt, R. R., Kazlauskas, A., and DiMaio, D. (1995). Ligand-independent activation of the platelet-derived growth factor β receptor: requirements for bovine papillomavirus E5-induced mitogenic signaling. Mol. Cell. Biol. 15, 2570-2581.
25. Tomic, S., Greiser, U., Lammers, R., Kharitonenkov, A., Imyanitov, E., Ullrich, A., and Böhmer, F. D. (1995). Association of SH2 domain protein tyrosine phosphatases with the epidermal growth factor receptor in human tumor cells: Phosphatidic acid activates receptor dephosphorylation by PTP1C. J. Biol. Chem. 270, 21277-21284.
26. Knebel, A., Rahmsdorf, H. J., Ullrich, A., and Herrlich, P. (1996). Dephosphorylation of receptor tyrosine kinase as target of regulation by radiation, oxidants or alkylating agents. EMBO J. 15, 5314-5322.
27. Elenius, K., Paul, S., Allison, G., Sun, J., and Klagsbrun, M. (1997). Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation. EMBO J. 16, 1268-1278.
28. Guy, P. M., Platko, J. V., Cantley, L. C., Cerione, R. A., and Carraway, K. L. (1994). Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity. Proc. Natl. Acad. Sci. USA 91, 8132-8136.
29. Riese, D. J., Kim, E. D., Elenius, K., Buckley, S., Klagsbrun, M., Plowman, G. D., and Stern, D. F. (1996). The epidermal growth factor receptor couples transforming growth factor-α, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4. J. Biol. Chem. 271, 20047-20052.
30. Gamett, D. C., Pearson, G., Cerione, R. A., and Friedberg, I. (1997). Secondary dimerization between members of the epidermal growth factor receptor family. J. Biol. Chem. 272, 12052-12056.